Active Surveillance Versus Adjuvant Intravesical Chemotherapy in Liquid Biopsy-Defined Low-Shedding Intermediate-Risk NMIBC

Clinical trial NCT07749924 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07749924
Sponsor: Tianjin Medical University Second Hospital
Status: NOT_YET_RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Bladder Cancer Non-Muscle-Invasive Bladder Cancer (NMIBC)

Start date: 2026-08-10
Primary completion: 2029-03-01
Enrollment: 670

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.